What is the official website of Beckman Coulter Life Sciences Brazil ?

The official website of Beckman Coulter Life Sciences Brazil is http://mybeckman.com.br.

What is Beckman Coulter Life Sciences Brazil's cybersecurity risk score?

Beckman Coulter Life Sciences Brazil has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Beckman Coulter Life Sciences Brazil experienced?

According to Rankiteo, Beckman Coulter Life Sciences Brazil currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Beckman Coulter Life Sciences Brazil been affected by any supply chain cyber incidents ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Beckman Coulter Life Sciences Brazil have SOC 2 Type 1 certification ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil is not certified under SOC 2 Type 1.

Does Beckman Coulter Life Sciences Brazil have SOC 2 Type 2 certification ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil does not hold a SOC 2 Type 2 certification.

Does Beckman Coulter Life Sciences Brazil comply with GDPR ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil is not listed as GDPR compliant.

Does Beckman Coulter Life Sciences Brazil have PCI DSS certification ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil does not currently maintain PCI DSS compliance.

Does Beckman Coulter Life Sciences Brazil comply with HIPAA ?

According to Rankiteo, Beckman Coulter Life Sciences Brazil is not compliant with HIPAA regulations.

Does Beckman Coulter Life Sciences Brazil have ISO 27001 certification ?

According to Rankiteo,Beckman Coulter Life Sciences Brazil is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Beckman Coulter Life Sciences Brazil operate in ?

Beckman Coulter Life Sciences Brazil operates primarily in the Biotechnology Research industry.

How many employees does Beckman Coulter Life Sciences Brazil have ?

Beckman Coulter Life Sciences Brazil employs approximately None employees people worldwide.

Does Beckman Coulter Life Sciences Brazil own any subsidiaries ?

Beckman Coulter Life Sciences Brazil presently has no subsidiaries across any sectors.

How many LinkedIn followers does Beckman Coulter Life Sciences Brazil have ?

Beckman Coulter Life Sciences Brazil's official LinkedIn profile has approximately 3,360 followers.

What is the NAICS classification code for Beckman Coulter Life Sciences Brazil ?

Beckman Coulter Life Sciences Brazil is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Beckman Coulter Life Sciences Brazil have a Crunchbase profile ?

No, Beckman Coulter Life Sciences Brazil does not have a profile on Crunchbase.

Does Beckman Coulter Life Sciences Brazil have a LinkedIn profile ?

Yes, Beckman Coulter Life Sciences Brazil maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/beckmancoulterpor.

How many cybersecurity incidents has Beckman Coulter Life Sciences Brazil experienced ?

As of July 24, 2026, Rankiteo reports that Beckman Coulter Life Sciences Brazil has not experienced any cybersecurity incidents.

How many peer or competitor companies does Beckman Coulter Life Sciences Brazil have ?

Beckman Coulter Life Sciences Brazil has an estimated 4,731 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BCLSB

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Beckman Coulter Life Sciences Brazil Vendor Cyber Rating & Cyber Score

mybeckman.com.br

Add Your Compliance Badge

Biotecnologia. Ciências da Vida. Pesquisa. Fabricação de precisão. A Beckman Coulter Life Sciences é referência nestes campos. Desde 1935, o nome Beckman é sinônimo de tecnologias que simplificam e automatizam testes biomédicos complexos. Décadas depois, nossa organização global também passou a incorporar o legado científico do nome Coulter. Hoje, a Beckman Coulter Life Sciences é uma empresa global confiável para ferramentas que ajudam a otimizar a eficiência da pesquisa e da fabricação. Centrífugas. Contadores / analisadores de partículas. Manipuladores de líquidos automatizados, citômetros de fluxo. Todos esses produtos - e muitos outros - continuam fazendo a diferença na vida das pessoas, melhorando a produtividade de cientistas

BCLSB A.I CyberSecurity Scoring

Scoring History

BCLSB

Beckman Coulter Life Sciences Brazil CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

BCLSB Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BCLSB

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Beckman Coulter Life Sciences Brazil in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Beckman Coulter Life Sciences Brazil in 2026.

Incident Types BCLSB vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Beckman Coulter Life Sciences Brazil in 2026.

Incident History - BCLSB (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Beckman Coulter Life Sciences Brazil Subsidiaries

BCLSB

Biotechnology Research

Website: http://mybeckman.com.br

Company Size: 1,001-5,000 employees

Beckman Coulter Life SciencesBiotechnology Research

Danaher CorporationMedical Equipment Manufacturing

Beckman Coulter DiagnosticsMedical Equipment Manufacturing

Beckman Coulter Dx BrasilFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx North AmericaMedical Equipment Manufacturing

Beckman Coulter Dx LATAMFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx EEMEAتصنيع المعدات الطبية

Beckman Coulter Dx Asia PacificMedical Equipment Manufacturing

한국벡크만쿨터의료장비 제조

CepheidBiotechnology Research

CytivaBiotechnology Research

Pall Medical, part of CytivaMedical Equipment Manufacturing

Cytiva LATAMPesquisa biotecnológica

Pall CorporationManufacturing

Pall - Energy+Machinery Manufacturing

Aria FiltraEnvironmental Services

Pall - Food & BeverageFood and Beverage Services

Pall - AerospaceAviation and Aerospace Component Manufacturing

Pall - Energy+Machinery Manufacturing

Pall - MicroelectronicsAppliances, Electrical, and Electronics Manufacturing

Leica MicrosystemsMedical Equipment Manufacturing

Leica Microsystems MedicalHospitals and Health Care

Integrated DNA TechnologiesBiotechnology Research

CRISPR genome editing by IDTBiotechnology Research

Leica BiosystemsMedical Device

Leica Biosystems EMEAMedical Equipment Manufacturing

RadiometerMedical Equipment Manufacturing

AbcamBiotechnology Research

PhenomenexBiotechnology Research

Phenomenex - EMEABiotechnology

Molecular DevicesBiotechnology Research

Clone Screening | Molecular DevicesBiotechnology Research

FLIPR Penta Drug Screening | Molecular DevicesBiotechnology Research

Molecular Devices IndiaBiotechnology Research

Axon Patch-Clamp | Molecular DevicesBiotechnology Research

High-Content Imaging & Analysis | Molecular DevicesBiotechnology Research

High-Content Imaging | Molecular DevicesBiotechnology Research

3D Biology | Molecular DevicesBiotechnology Research

Molecular Devices China生物技术研究

Beckman Coulter Diagnostics EuropeMedical Equipment Manufacturing

AldevronBiotechnology Research

Danaher Life SciencesBiotechnology Research

IDBSSoftware Development

PolarSoftware Development

Beckman Coulter Dx India & SWAMedical Equipment Manufacturing

SCIEXBiotechnology Research

SCIEX Food & Environmental Testing SolutionsBiotechnology Research

SCIEX Biopharma & Pharma SolutionsBiotechnology Research

SCIEX Omics SolutionsBiotechnology

SCIEX Forensic Testing SolutionsBiotechnology Research

SCIEX Service & SupportMedical Equipment Manufacturing

SCIEX Clinical ApplicationsMedical Equipment Manufacturing

SCIEX LatinoaméricaPesquisa biotecnológica

Beckman Coulter Dx TurkeyTıbbi Ekipman İmalatı

Danaher India Development CenterIT System Custom Software Development

Beckman Coulter Dx Eastern EuropeVýroba zdravotnických prostředků

Beckman Coulter Dx China生物技术研究

HemoCue ABMedical Equipment Manufacturing

Danaher DiagnosticsMedical Equipment Manufacturing

MammotomeMedical Equipment Manufacturing

GenedataBiotechnology Research

ジーンデータ（株）/ Genedata KKバイオテクノロジー研究

Beckman Coulter Life Sciences India, SWA, METAIBiotechnology Research

Beckman Coulter Life Sciences TASK RegionBiotechnology Research

Beckman Coulter Life Sciences LATAMBiotechnology Research

Loading…

Beckman Coulter Life Sciences Brazil Similar Companies

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Loading…

NEWS

Beckman Coulter Life Sciences Brazil CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-50044

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 7.6

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

1.6

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-44955

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-42933

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 10)

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 10.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-40430

SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-28698

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…